Dixon Technologies stock climbed up to 6% on Monday after brokerage Investec raised its target price to ₹16,200. The upgrade reflects optimism toward the company's entry into speciality electronics manufacturing and stabilizing demand for mobile devices. Investors are closely watching for an earnings acceleration expected from the second half of FY27 as export volumes rise.
Dixon Technologies shares saw a sharp move on Monday, rising nearly 6 percent to reach a high of ₹13,161 on the National Stock Exchange. The upward momentum follows a report from Investec, which maintained a positive outlook on the stock and increased its target price to ₹16,200, representing a significant potential upside from its previous close. This gain adds to a five-session winning streak for the company, during which the stock has risen by more than 10 percent.
Strategic Pivot to Speciality EMS
A primary driver behind the analyst optimism is Dixon Technologies' expansion into the speciality electronics manufacturing services (EMS) segment. Unlike traditional EMS, which focuses on high-volume, low-margin assembly, the speciality segment often involves higher value-added processes and components. This strategic move is intended to improve the company's product mix and long-term earnings potential. Alongside this, Investec raised its earnings per share estimates for the company for fiscal years 2027 and 2028 by 6 to 8 percent, citing stronger management guidance on mobile phone volumes.
Sector Trends and Earnings Outlook
The broader electronics manufacturing sector in India is experiencing a shift as global brands move parts of their supply chain away from Chinese providers toward Indian manufacturers. This trend has provided a tailwind for Dixon. While the company faces a temporary period of stable operating margins in the first half of FY27—partly due to the gradual phase-out of certain Production Linked Incentive (PLI) benefits—analysts expect a notable increase in earnings starting in the second half of the year. The company's focus on growing its mobile export business is viewed as a crucial factor in this projected recovery.
Monitoring Future Growth
For investors, the next important phase will be tracking the actual execution of the speciality EMS business and the sustainability of mobile demand. While the stock has seen a positive reaction to the analyst upgrade, the real impact on the balance sheet will depend on how effectively the company can scale these new high-value operations. Additionally, the transition away from specific government incentives means that profit margins will be closely watched in upcoming quarterly results to see if the growth in exports can offset the loss of those benefits. The company's ability to maintain its market share in the face of intense competition within the EMS sector remains a factor to monitor as the fiscal year progresses.